Minister of Health tables review board’s annual report with the Senate and House of Commons.
Pharmaceutical association says draft guidelines will exacerbate an already unpredictable regulatory environment.
New guideline will explain procedures used to monitor price of medicines.
In 2019, seven of the top ten selling patented drugs had annual treatment costs of more than $10,000 per year, says the
The CLHIA has called on the Ontario government to recognize the Harmonized Life License Qualification Program when setti
Review Board sets out on 30-day public consultations on draft pricing guidelines for medicines.
High-cost, specialty medicines account for an ever-increasing proportion of new treatments coming to market, reveals a n